Elizabeth A. Garofalo Acadia Pharmaceuticals Inc (ACAD) insider trading activity

Elizabeth A. Garofalo is of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 25,382 shares of ACAD, which is worth approximately $609,675. The most recent transaction as insider was on Sep 02, 2025, when has been sold 1,600 shares (Common Stock) at a price of $25.98 per share, resulting in proceeds of $41,568. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.4K

0% 3M change

12.74% 12M change

Total Value Held $609,675

ELIZABETH A. GAROFALO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 02 2025	SELL Open market or private sale	$41,568 $25.98 p/Share	1,600 Reduced 5.93%	25,382 Common Stock
May 29 2025	BUY Exercise of conversion of derivative security	-	9,387 Added 25.81%	26,982 Common Stock
Mar 05 2025	SELL Open market or private sale	$89,673 $18.23 p/Share	4,919 Reduced 21.85%	17,595 Common Stock
May 29 2024	BUY Exercise of conversion of derivative security	-	6,652 Added 22.81%	22,514 Common Stock
Nov 24 2023	SELL Bona fide gift	-	2,918 Reduced 15.54%	15,862 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	-	8,552 Added 31.29%	18,780 Common Stock
Sep 29 2022	BUY Exercise of conversion of derivative security	-	1,919 Added 15.8%	10,228 Common Stock

Jun 07 2022	BUY Exercise of conversion of derivative security	-	6,391 Added 43.48%	8,309 Common Stock
Sep 29 2021	BUY Exercise of conversion of derivative security	-	1,918 Added 50.0%	1,918 Common Stock

Also insider at

XCUR

EXICURE, INC. Healthcare

Director

XENE

Xenon Pharmaceuticals Inc. Healthcare

ALEC

Alector, Inc. Healthcare

EAG